` Comparison: RX vs MRK - Alpha Spread

RX
vs
MRK

Over the past 12 months, RX has underperformed MRK, delivering a return of +15% compared to the MRK's +41% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RX
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RX Intrinsic Value
12.42 CAD
Overvaluation 3%
Intrinsic Value
Price
MRK Intrinsic Value
113.84 USD
Overvaluation 7%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biosyent Inc
XTSX:RX
12.77 CAD
Merck & Co Inc
NYSE:MRK
122.06 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RX, MRK

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biosyent Inc
Revenue
Merck & Co Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
RX, MRK

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biosyent Inc
XTSX:RX
Merck & Co Inc
NYSE:MRK
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

RX
77.5%
MRK
81.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

Operating Margin

RX
25.7%
MRK
41.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

Net Margin

RX
20.5%
MRK
28.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

FCF Margin

RX
19.2%
MRK
20.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

ROE

RX
22.4%
MRK
37.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

ROA

RX
18.5%
MRK
14.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

ROIC

RX
39.6%
MRK
22.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

ROCE

RX
27.4%
MRK
28.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Biosyent Inc
Merck & Co Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
RX, MRK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RX, MRK

Loading
RX
MRK
Difference
www.alphaspread.com

Performance By Year
RX, MRK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RX to other stocks
LLY
Eli Lilly and Co
JNJ
Johnson & Johnson
ROG
Roche Holding AG
NOVN
Novartis AG
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account